Free Trial

Anpario (LON:ANP) Stock Crosses Below Two Hundred Day Moving Average - Here's What Happened

Anpario logo with Consumer Defensive background

Key Points

  • Anpario plc's stock price fell below its two hundred day moving average of GBX 415.98, closing at GBX 415.50 during trading.
  • The company's financial metrics include a debt-to-equity ratio of 0.10 and a market cap of £70.89 million.
  • Anpario specializes in producing natural feed additives for animal health, focusing on gut health and feed quality solutions.
  • Interested in Anpario? Here are five stocks we like better.

Shares of Anpario plc (LON:ANP - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 415.98 ($5.57) and traded as low as GBX 405 ($5.42). Anpario shares last traded at GBX 415.50 ($5.57), with a volume of 16,543 shares changing hands.

Anpario Price Performance

The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16. The stock has a fifty day simple moving average of GBX 404.13 and a 200-day simple moving average of GBX 414.63. The company has a market capitalization of £68.55 million, a price-to-earnings ratio of 1,656.43 and a beta of 0.58.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.